Molecular Mechanisms of Pulmonary Arterial Remodeling
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 20 (1) , 191-201
Abstract
Pulmonary arterial hypertension (PAH) is characterized by a persistent elevation of pulmonary arterial pressure and pulmonary arterial remodeling with unknown etiology. Current therapeutics available for PAH are primarily directed at reducing the pulmonary blood pressure through their effects on the endothelium. It is well accepted that pulmonary arterial remodeling is primarily due to excessive pulmonary arterial smooth muscle cell (PASMC) proliferation that leads to narrowing or occlusion of the pulmonary vessels. Future effective therapeutics will be successful in reversing the vascular remodeling in the pulmonary arteries and arterioles. The purpose of this review is to provide updated information on molecular mechanisms involved in pulmonary arterial remodeling with a focus on growth factors, transcription factors, and epigenetic pathways in PASMC proliferation. In addition, this review will highlight novel therapeutic strategies for potentially reversing PASMC proliferation.Keywords
This publication has 98 references indexed in Scilit:
- MicroRNAs in pulmonary arterial remodelingCellular and Molecular Life Sciences, 2013
- Role for miR-204 in human pulmonary arterial hypertensionJournal of Experimental Medicine, 2011
- MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migrationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Upregulation of Oct-4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertensionJournal Of Hypertension, 2010
- Notch3 signaling promotes the development of pulmonary arterial hypertensionNature Medicine, 2009
- Cellular and Molecular Basis of Pulmonary Arterial HypertensionJACC, 2009
- KCNQ Modulators Reveal a Key Role for KCNQ Potassium Channels in Regulating the Tone of Rat Pulmonary Artery Smooth MuscleThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor β1Journal of Biological Chemistry, 2008
- Id family of helix-loop-helix proteins in cancerNature Reviews Cancer, 2005